Ionis Pharmaceuticals (IONS)
(Real Time Quote from BATS)
$51.49 USD
-0.37 (-0.71%)
Updated Jul 26, 2024 03:42 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO8/1/24 |
---|---|
Current Quarter | -0.99 |
EPS Last Quarter | -0.98 |
Last EPS Surprise | 10.91% |
ABR | 1.60 |
Earnings ESP
|
8.78% |
---|---|
Current Year | -3.93 |
Next Year | -3.42 |
EPS (TTM) | -2.67 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 143.65M | 151.03M | 595.85M | 743.45M |
# of Estimates | 9 | 9 | 9 | 9 |
High Estimate | 158.00M | 167.00M | 644.40M | 867.71M |
Low Estimate | 125.44M | 120.86M | 542.88M | 668.35M |
Year ago Sales | 188.00M | 144.00M | 788.00M | 595.85M |
Year over Year Growth Est. | -23.59% | 4.88% | -24.38% | 24.77% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.99 | -1.00 | -3.93 | -3.42 |
# of Estimates | 9 | 8 | 10 | 10 |
Most Recent Consensus | -0.74 | -0.82 | -3.46 | -3.03 |
High Estimate | -0.74 | -0.83 | -3.33 | -2.29 |
Low Estimate | -1.14 | -1.28 | -4.47 | -4.61 |
Year ago EPS | -0.60 | -1.03 | -2.56 | -3.93 |
Year over Year Growth Est. | -65.00% | 2.91% | -53.52% | 12.98% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 0 | 2 | 1 |
Up Last 30 Days | 3 | 2 | 2 | 3 |
Up Last 60 Days | 4 | 3 | 3 | 4 |
Down Last 7 Days | 1 | 1 | 0 | 1 |
Down Last 30 Days | 1 | 0 | 3 | 3 |
Down Last 60 Days | 1 | 0 | 4 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.99 | -1.00 | -3.93 | -3.42 |
7 Days Ago | -0.99 | -1.00 | -3.96 | -3.42 |
30 Days Ago | -1.03 | -1.03 | -3.95 | -3.40 |
60 Days Ago | -1.04 | -1.04 | -3.98 | -3.44 |
90 Days Ago | -1.08 | -1.05 | -3.85 | -3.25 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.90 | -0.95 | -3.75 | -3.20 |
Zacks Consensus Estimate | -0.99 | -1.00 | -3.93 | -3.42 |
Earnings ESP | 8.78% | 5.62% | 4.51% | 6.45% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.98 | -0.06 | -1.03 | -0.60 | NA |
Estimate | -1.10 | -0.78 | -1.01 | -0.94 | NA |
Difference | 0.12 | 0.72 | -0.02 | 0.34 | 0.29 |
Surprise | 10.91% | 92.31% | -1.98% | 36.17% | 34.35% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more